December 6, 2022
Researchers to Investigate Genetic Variants Associated with Rare Pediatric Diseases MENLO PARK, Calif. -- PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced its HiFi sequencing technology will be used in a pilot project for the Children's Rare Disease Cohorts Initiative (CRDC) at Boston Children's Hospital. Boston Children's Hospital researchers will use HiFi whole-genome sequencing (HiFi WGS) for the purpose of investigating genetic [...]
Single-objective light sheet microscope launched at Cell Bio 2022
December 6, 2022
Leica Microsystems and ASI announce partnership to commercialize customizable microscope for advanced users Cell Bio, December 3-7, 2022, Booth #2025 Wetzlar, Germany – Leica Microsystems, a leader in microscopy and scientific instrumentation, has entered into a partnership with Applied Scientific Instrumentation (ASI) to commercialize single-objective light-sheet microscopy. The advanced system was unveiled for the first [...]
MilliporeSigma Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition
December 6, 2022
Erbi’s differentiated 2 ml micro-bioreactor platform technology, Breez™, enables rapid lab testing for bioprocessing scale up Allows MilliporeSigma to offer full range of bioreactors, from 2ml to 2000L Adds to company’s expertise in monoclonal antibody (mAb) process development Burlington, Massachusetts – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading [...]
December 6, 2022
Company to achieve 2030 Scope 1 and 2 greenhouse gas emissions reduction target of 30% ahead of schedule; increases ambition to 50% reduction, aligned with 1.5˚C pathway WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a new 2030 greenhouse gas emissions reduction target to reduce its [...]
Thermo Fisher Scientific Launches TrueMark Infectious Disease Research Panels
December 6, 2022
Assays can detect more than 90 different disease pathogens CARLSBAD, Calif. -- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TrueMark Infectious Disease Research Panels designed to enable rapid and accurate detection and categorization for investigating microorganisms that cause respiratory, vaginal, urinary, gastrointestinal, and sexually transmitted diseases. To [...]
December 6, 2022
Products Represent the Highest Plex In Situ Imager and the First Cloud-Based Data Analysis Suite for Spatial Biology SEATTLE -- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the first commercial shipment of the CosMx™ Spatial Molecular Imager (SMI) and the AtoMx™ Spatial Informatics [...]
Molecular Devices adds proprietary patient-derived organoid technology with acquisition of Cellesce
December 6, 2022
First-of-its-kind technology from Cellesce creates consistent patient-derived organoids for large scale drug screening Acquisition strengthens Molecular Devices’ position as a 3D biology solutions innovator Combined expertise will accelerate industry adoption of physiologically-relevant cell models for drug discovery SAN JOSE, Calif., and CARDIFF, Wales – Molecular Devices, LLC., a leading provider of high-performance life science solutions, [...]
December 6, 2022
RICHMOND, Va. -- Grenova, creator of the laboratory industry's only patented technology for washing and reusing plastic consumables, announced today that it has earned ISO 9001:2015 and ISO 13485:2016 certification as part of the company's mission to make laboratories around the world sustainable, resilient, cost-effective, and highly efficient. The International Organization for Standardization (ISO) develops and publishes [...]
Congenica awarded second stage of European contract to develop NGS analysis workflow in oncology
December 6, 2022
CAMBRIDGE, England -- Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has been awarded the second stage of a contract to develop standardised Next-Generation Sequencing (NGS) workflows in oncology for a group of seven Central European hospitals represented by the Medical University Graz. The European Union Horizon [...]
December 6, 2022
Pierian®, a global leader in advanced clinical genomics technology and services, announced a collaboration to support PreCheck Health Services, a CLIA-registered, CAP-accredited high complexity laboratory, in providing cancer-related genomic testing programs for medical practices and patients in addition to the launch of an in-house next-generation sequencing (NGS) program. Read our full press release by clicking [...]

